Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust - Study 1

NCT ID: NCT06650462

Last Updated: 2025-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

57 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-02

Study Completion Date

2025-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to assess how community-led group discussions about health-related topics may alter beliefs and intentions regarding healthcare recommendations, such as COVID-19 testing and vaccination.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Eligible participants will be randomized to intervention or control group. Intervention group participants will meet virtually with other community member participants in small discussion groups once a week for one hour over the course of 12 weeks. The online discussion groups will be led by peer mentor facilitators and supported by a research team member. Discussion topics will include current events, COVID-19, and other health related topics. Control group participants will not meet in weekly discussion groups. At approximately the 0 month, 3 month, and 6 month time points, all participants will answer online surveys about health related topics. At the 3 month and 6 month time points, all participants will also be asked to self-administer a COVID-19 test that investigators provide. Finally, around the fourth month, intervention group participants will be invited to an online feedback session with the research team about participants' experiences in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Trust

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants randomly assigned to intervention or control group; repeated measure assessments at 0 months, 3 months, 6 months
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

non-intervention control (participants complete surveys only)

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention

Participants engage in weekly community-led small group discussions about health-related topics and answer surveys at 0, 3, and 6 months time points

Group Type EXPERIMENTAL

Community-led discussion

Intervention Type BEHAVIORAL

Participants engage in weekly community-led small group discussions about health related topics

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Community-led discussion

Participants engage in weekly community-led small group discussions about health related topics

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* Resident of one of the 9 housing authority agencies
* Willing to participate in Zoom meetings and complete online assessments at baseline, 3-month, and 6-month timepoints
* Ability to read, speak, and understand English

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Old Dominion University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kelli J. England

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kelli J England, PhD

Role: PRINCIPAL_INVESTIGATOR

Old Dominion University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Macon & Joan Brock Virginia Health Institute at Old Dominion University

Norfolk, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22-10-FB-0215 - Study 1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

COVID-19 Booster Readiness Survey
NCT05529030 COMPLETED NA
COVID-19 Vaccination Take-Up
NCT04867174 COMPLETED NA
Minnesota COVID-19 Testing Project
NCT04568889 COMPLETED NA
COVID-19 and Mental Health
NCT04407195 COMPLETED